CCM
Compton Capital Management Portfolio holdings
AUM
$4.32M
Turnover
83.33%
1-Year Est. Return
27.38%
This Fund
S&P 500
This Quarter
Est. Return
+1.21%
1 Year Est. Return
+27.38%
3 Year Est. Return
+75.57%
5 Year Est. Return
+123.58%
10 Year Est. Return
+303.58%
AUM
$180M
AUM Growth
-$3.78M
(-2.1%)
Cap. Flow
-$3.66M
Cap. Flow
% of AUM
-2.04%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
144
New
1
Increased
32
Reduced
64
Closed
6
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.13M |
| 2 |
PPL Corp
PPL
|
+$1.07M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$260K |
| 4 |
Community Health Systems
CYH
|
+$243K |
| 5 |
Ford
F
|
+$124K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.6M |
| 2 |
Chevron
CVX
|
+$1M |
| 3 |
ExxonMobil
XOM
|
+$853K |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$697K |
| 5 |
Apple
AAPL
|
+$277K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.96% |
| 2 | Technology | 17.95% |
| 3 | Financials | 14.2% |
| 4 | Industrials | 11.75% |
| 5 | Communication Services | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$5.01T
| $14.6M | 8.1% |
467,976
-9,168
| -2% | -$277K |
2013 Q2
7 quarters
|
|
|
2
ExxonMobil
XOM
$728B
| $6.24M | 3.47% |
73,378
-9,616
| -12% | -$853K |
2013 Q2
7 quarters
|
|
3
Cisco
CSCO
$448B
| $5.91M | 3.29% |
214,749
+3,070
| +1% | +$86.4K |
2013 Q2
7 quarters
|
|
4
Gilead Sciences
GILD
$190B
| $5.88M | 3.27% |
70,085
-650
| -0.9% | -$66K |
2013 Q2
7 quarters
|
|
5
JPMorgan Chase
JPM
$890B
| $5.45M | 3.03% |
89,959
+138
| +0.2% | +$8.17K |
2013 Q2
7 quarters
|
|
6
GE Aerospace
GE
$319B
| $5.24M | 2.92% |
44,078
+364
| +0.8% | +$43.3K |
2013 Q2
7 quarters
|
|
|
7
Alphabet (Google) Class C
GOOG
$4.2T
| $4.53M | 2.52% |
175,521
+9,707
| +6% | +$260K |
2013 Q2
7 quarters
|
|
8
Invesco Preferred ETF
PGX
$3.6B
| $4.3M | 2.39% |
288,100
-500
| -0.2% | -$7.41K |
2013 Q2
7 quarters
|
|
9
Nike
NKE
$52.4B
| $4.09M | 2.27% |
81,466
-2,600
| -3% | -$124K |
2013 Q2
7 quarters
|
|
10
Verizon
VZ
$185B
| $3.9M | 2.17% |
80,172
-1,718
| -2% | -$82.9K |
2013 Q2
7 quarters
|
|
|
CELG
11
DELISTED
Celgene Corp
CELG
| $3.59M | 2% |
31,120
-666
| -2% | -$79.6K |
2013 Q2
7 quarters
|
|
12
Procter & Gamble
PG
$364B
| $3.25M | 1.81% |
39,691
-330
| -0.8% | -$28.4K |
2013 Q2
7 quarters
|
|
13
Lowe's Companies
LOW
$106B
| $3.25M | 1.81% |
43,655
-700
| -2% | -$50.2K |
2013 Q2
7 quarters
|
|
14
CVS Health
CVS
$116B
| $3.1M | 1.73% |
30,043
-1,325
| -4% | -$134K |
2013 Q2
7 quarters
|
|
15
Blackstone
BX
$79.7B
| $3.1M | 1.72% |
81,163
-1,223
| -1% | -$44.2K |
2013 Q2
7 quarters
|
|
16
PepsiCo
PEP
$176B
| $2.99M | 1.66% |
31,253
-430
| -1% | -$41.6K |
2013 Q2
7 quarters
|
|
17
Wells Fargo
WFC
$243B
| $2.7M | 1.5% |
49,712
-790
| -2% | -$42.7K |
2013 Q2
7 quarters
|
|
|
VAR
18
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.48M | 1.38% |
30,055
| – | – |
2013 Q2
7 quarters
|
|
19
3M
MMM
$84.8B
| $2.45M | 1.36% |
17,771
-568
| -3% | -$78.3K |
2013 Q2
7 quarters
|
|
20
Thermo Fisher Scientific
TMO
$249B
| $2.42M | 1.35% |
18,037
-405
| -2% | -$52.2K |
2013 Q2
7 quarters
|
|
21
Johnson & Johnson
JNJ
$612B
| $2.34M | 1.3% |
23,253
+50
| +0.2% | +$5.08K |
2013 Q2
7 quarters
|
|
22
Berkshire Hathaway Class B
BRK.B
$1.13T
| $2.27M | 1.26% |
15,749
-380
| -2% | -$55.9K |
2013 Q2
7 quarters
|
|
|
23
Chevron
CVX
$436B
| $2.27M | 1.26% |
21,594
-9,389
| -30% | -$1M |
2013 Q2
7 quarters
|
|
|
24
Medtronic
MDT
$121B
| $2.21M | 1.23% |
28,398
+14,893
| +110% | +$1.13M |
2013 Q2
7 quarters
|
|
25
Bristol-Myers Squibb
BMY
$121B
| $2.15M | 1.2% |
33,334
-500
| -1% | -$31.3K |
2013 Q2
7 quarters
|
|
Similar funds
GPCM
MAM
BGCI
CAM
EAM
SM
TPL
RC
Compton Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Compton Capital Management held 144 positions worth $180M, down 2.1% from $183M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 4.9%. Compton Capital Management opened 1 new position and exited 6, leaving the 144-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Technology and Financials.
- Compton Capital Management's largest Q1 2015 buy was Community Health Systems: 5,869 shares worth $254K.
- Compton Capital Management added most to Medtronic in Q1 2015, an estimated $1.13M increase.
- Compton Capital Management's biggest Q1 2015 reduction was Chevron, cutting an estimated $1M.
- Compton Capital Management fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $1.6M.
- Compton Capital Management's ten largest holdings make up 33% of its $180M portfolio in Q1 2015.
- Compton Capital Management opened 1 new position and closed 6 in Q1 2015.
- Compton Capital Management's portfolio value fell 2.1% quarter-over-quarter to $180M.
Based on Compton Capital Management's 13F filing for Q1 2015, filed 14 May 2015.